Sekar Kathiresan
Founder en VERVE THERAPEUTICS, INC. .
Fortuna: 8 M $ al 31/03/2024
Perfil
Sekar Kathiresan is the founder of Maze Therapeutics, Inc. (founded in 2018) and Verve Therapeutics, Inc. (founded in 2018).
He is currently the Chief Executive Officer & Director at Verve Therapeutics, Inc. and a Director at Maze Therapeutics, Inc. (founded in 2022).
Dr. Kathiresan's current job is as an Independent Director at Relay Therapeutics, Inc. (since 2022).
He previously held positions as a Director at the Center for Genomic Medicine Massachusetts General Hospital (2016-2019), Director-Cardiovascular Disease Initiative at The Broad Institute, Inc. (2014-2019), Assistant Physician at The General Hospital Corp.
(1997-2021), and Professor at Harvard Medical School (2018-2021).
Dr. Kathiresan received his undergraduate degree from the University of Pennsylvania and his doctorate from Harvard Medical School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VERVE THERAPEUTICS, INC.
0.81% | 14/02/2024 | 639 833 ( 0.81% ) | 8 M $ | 31/03/2024 |
RELAY THERAPEUTICS, INC.
-.--% | 04/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Sekar Kathiresan
| Empresas | Cargo | Inicio |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Founder | 01/01/2018 |
| RELAY THERAPEUTICS, INC. | Director/Board Member | 25/07/2022 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Founder | 01/04/2022 |
Antiguos cargos conocidos de Sekar Kathiresan.
| Empresas | Cargo | Fin |
|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/08/2021 |
| Harvard Medical School | Corporate Officer/Principal | 01/06/2021 |
| Center for Genomic Medicine Massachusetts General Hospital | Director/Board Member | 01/06/2019 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2019 |
Formación de Sekar Kathiresan.
| University of Pennsylvania | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| RELAY THERAPEUTICS, INC. | Health Technology |
| VERVE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Commercial Services |
| Center for Genomic Medicine Massachusetts General Hospital |
- Bolsa de valores
- Insiders
- Sekar Kathiresan
